Switch to:

Denali Therapeutics EPS (Basic)

: $-0.68 (TTM As of Sep. 2019)
View and export this data going back to 2017. Start your Free Trial

Denali Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Sep. 2019 was $-0.48. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.68.

Denali Therapeutics's EPS (Diluted) for the three months ended in Sep. 2019 was $-0.48. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2019 was $-0.71.

Denali Therapeutics's EPS without NRI for the three months ended in Sep. 2019 was $-0.48. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2019 was -0.71.

During the past 3 years, the average EPS without NRI Growth Rate was 58.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Denali Therapeutics's highest 3-Year average EPS without NRI Growth Rate was 58.80% per year. The lowest was 58.80% per year. And the median was 58.80% per year.


Denali Therapeutics EPS (Basic) Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
EPS (Basic) -5.58 -13.49 -5.89 -0.39

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
EPS (Basic) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.38 0.82 -0.41 -0.61 -0.48

Denali Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Denali Therapeutics's Basic EPS for the fiscal year that ended in Dec. 2018 is calculated as

Basic EPS (A: Dec. 2018 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-36.24-0)/92.622
=-0.39

Denali Therapeutics's Basic EPS for the quarter that ended in Sep. 2019 is calculated as

Basic EPS (Q: Sep. 2019 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-46.26-0)/95.859
=-0.48

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2019 was 0.82 (Dec. 2018 ) + -0.41 (Mar. 2019 ) + -0.61 (Jun. 2019 ) + -0.48 (Sep. 2019 ) = $-0.68

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics  (NAS:DNLI) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Denali Therapeutics EPS (Basic) Related Terms


Denali Therapeutics EPS (Basic) Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */